Growth arrested human diploid fibroblast line, TIG-1, is induced to synthesize DNAfollowing stimulation with various peptide growth factors such as serum, epidermal growth factor (EGF), and DNAsynthesis factors (26) . This cell line is also stimulated to synthesize DNAby other agents as 12-O-tetradecanoylphorbol-1 3-acetate (TPA), teleosidine, colchicine, colcemid, vinblastin, vincristin, or TNI6 (26) . Generally these nonpeptide agents individually are very weak inducers of DNAsynthesis in various cell lines, but are active as fetal bovine serum in early-passaged TIG-1.
It has been shown that protein kinase C (PKC) is activated by diacylglyceride derived from phosphatidylinositides which are hydrolyzed by phospholipase C through the action of several growth factors including platelet-derived growth factor, fibroblast growth factor, bombesin and vasopressin (4, 15, 25) . PKC is a receptor of TPA which is the potent activator of PKC (2, 13, 17, 18) . Activation of PKC induces several cell cycle dependent genes such as c-fos and c-myc and lets cells traverse from the Goto the S phase (7, 24) . Contrary to the mitogenic action of PKC,it has also been reported that TPAinhibits the induction of DNAsynthesis or cell proliferation (1). However, the mode of antiproliferative action of TPAhas not been studied extensively except in smooth muscle cells (8, 9) . In the present paper we report that in the human fibroblast, TIG-1 , TPAitself has a potent stimulatory effect on the induction of DNAsynthesis but it also showed inhibitory effects on the induction of DNAsynthesis induced by colcemid. This dual effect suggests that the former is mediated by staurosporine-sensitive PKCand the latter by staurosporine-insensitive PKC. Human diploid fibroblasts, TIG-1, were cultured as described previously (26) . They have a proliferative lifespan, about 60 population doublings, and becomes less responsive to various growth factors (26) . Weused them at the 25-45 population doubling level.
MATERIALS AND METHODS

Materials
Assay ofDNAsynthesis. DNAsynthesis was assayed by measuring the incorporation of [3H]thymidine into acid insoluble materials (20) or by autoradiography (6). The cells were plated on 13-mmround cover slips in 24-multiwell, and were cultured until they became subconfluent. Then they were growth-arrested in Go phase by maintaining subconfluent cultures in serum-deprived (0,5%) medium fbr 2-3 days as described (26 washed with phosphate-buffered saline, fixed with 10% formalin and washed extensively with water, rinsed with ethanol and air-dried. The radioactivity was determined with a liquid scintillation spectrometer. After determination of radioactivity, coverslips were rinsed with ethanol, air-dried and processed for autoradiography (6). Assay of PKC. The cells were washed with phosphate buffered saline and scraped. The cell pellet was homogenized in homogenizing buffer (20 mMTris-HCl, 50 mM2-mercaptoethanol, 5 mMEGTA, 2 mMEDTA, 2 fiM leupeptin, 100juM phenylmethylsulfonyl fluoride, pH 7.5) by Dounce A type homogenizer. The homogenate was centrifuged for 10 min at 1 ,500 x g and the resultant supernatant (postnuclear fraction) was recentrifuged for 30 min at 10,000 x g. The supernatant was saved as cytosol fraction. The pellet was suspended in homogenizing buffer containing 2% NP-40 and centrifuged for 30min at 10,000xg. The final supernatant was saved as membranefraction. PKCin each fraction was partially purified through DE52 columun (12). Binding of [3H]phorbol-12, 13-dibutyrate (16) and assay of enzyme activity using a synthetic octapeptide as a substrate (4, 5) were done as previously described.
Northern blot analysis. Isolation of RNAand analysis by Northern blot were done as reported previously on TIG-1 cells (10) .
RESULTS
Induction of DNAsynthesis in G0-arrested TIG-1. TIG-1 cells were growth-arrested in Go phase by culturing subconfluent cells in serum-deprived (0.5%) medium for 2-3 days. They entered the S phase following stimulation with serum, EGF, colcemid, or TPA (Table  I) as previously reported (26) . Entrance into the S phase began at about 14-16 h after growth stimulation (data not shown), though the extent of induction of DNAsynthesis varied amongexperiments. Stimulatory effect on DNAsynthesis by TPA and colcemid was highly dependent upon population doubling level (PDL) of TIG-1 as previously reported (26) , and was sometimes higher than that by serum before 30 PDL but generally lower after 35 PDL. Frequencies in cells entering the S phase monitored by autoradiography (Table I) into DNAis refered to as "induction of DNAsynthesis" or "entrance into the S phase" in the following experiments. Table I . Induction of DNAsynthesis in G0-arrested TIG-1.
Go-arrested TIG-1 was stimulated with various agents and labeled with [3H] thymidine (37 KBq/ml) for 36 h.
Whentwo stimulants were added simultaneously, no additive or synergistic effect for induction of DNAsynthesis was observed. Induction of DNAsynthesis by combination of two stimulants was generally not less than that observed after stimulation with one stimulant which showed higher response than the other (Table I) . However, when TPAwas added with EGFor colcemid, induction of DNAsynthesis was muchlower than expected. Wefocused the following experiments on the action of colcemid and TPA. In repeated experiments, colchicine and colcemid gave quantitatively similar effects at concentrations between 10~6-10~5 M and therefore, the results from only one of these conditions were presented in the following studies.
Activation of PKCfollowing growth stimulation.
Before studying the action of TPAand colcemid, the possible participation of PKCon the induction of DNA synthesis after addition of various growth stimulants was examined. Whenthe cells were stimulated with TPA, induction of DNAsynthesis was likely to be mediated by PKCactivation, because 1) translocation of (23), blocked induction of DNAsynthesis by TPA (Table II) ; and 4) PKC deprivation resulted in the inability of DNAinduction by TPA (Table III) . Onthe other hand, when the G0-arrested cells were stimulated with serum, EGF, colcemid or colchicine, the induction of DNAsynthesis appeared to be bypassed, or was not mediated, by PKC, because 1) down regulation of PKC did not occur (Fig. 1) ; 2) staurosporin did not block induction of DNAsynthesis (Table II) ; and 3) PKCdeprivation did not block but rather enhanced induction of DNAsynthesis (Table III) . Effect of colcemid and TPA on induction of DNA synthesis. When colcemid was added immediately (within a few minutes) after the addition of TPA, induction of DNAsynthesis was reduced: compare closed square (TPA alone) and closed circle (colcemid after TPA) at 0 time in Fig. 2 . However, the longer the interval between addition of TPAand colcemid, the similler the reduction of DNAsynthesis (Fig. 2, closed circles) . Whencolcemid was added more than 3 h later, DNA synthesis began to recover to the level of that induced by TPAalone. The reason why DNAsynthesis was re- 
TIG-1 was PKC-deprived and arrested in Go phase. It was stimulated with various agents and DNAsynthesis was assayed as described in legends to Table JI. 15,000 12 15 Go-arrested TIG-1 in 24-multiwell dishes was stimulated with various agents to induce DNA synthesis in the presence or absence of staurosporine. Incorporation of [3H]thymidine (37 KBq/ml) during 36 h was assayed. Parenthesis; percentage of incorporation in the presence of staurosporine to that in its absence.
Time of 2nd growth factor addition (h) Go-arrested TIG-1 was stimulated with TPA (10 ng/ml) alone ( å ) or also with colcemid (10~6 M) after various periods of time (indicated along abscissa) of TPAaddition (à"). Closed circle at 0 time represents point at which colcemid was addedwithin a few minutes after TPAaddition. G0-arrested TIG-1 was stimulated with colcemid alone duced when colcemid was added after 12 h is unclear. Conversely, when TPA was added immediately (within a few minutes) after colcemid addition, induction of DNAsynthesis was somewhat affected. However, the longer the interval between the addition of colcemid and TPA, the greater the reduction of DNAsynthesis (Fig. 2, open circles) .
It should be emphasized that colcemid or TPA was individually an inducer of DNAsynthesis and that during the majority of the culture period up to 39 h the cells were incubated in medium containing both colcemid and TPA, but that the extent of the induction of DNA synthesis was influenced by the order of addition of the two agents. An inhibitory effect of TPA on DNAsynthesis was also observed when TPAwas added after treatment of Go-arrested TIG-1 cells with serum or EGF, but it was very weak (data not shown). Whenphorbol was plained tentatively by the following: 1) the inhibitory effect on DNAsynthesis is expressed when the signal transduction process by colcemid is operating and, at the same time, activation of PKCoccurs; and 2) some of the molecular species of PKCare responsible for the inhibitory action of TPA by influencing the processes operating after colcemid treatment. In the experimental protocol of "TPA first and colcemid second", when colcemid was added within 3 h of TPAaddition, there was enough active PKCis available to bring out an inhibitory effect that is expressed through pathways driven by colcemid. Whencolcemid is added 6 h after TPA addition, PKCis no longer available, and so the inhibitory effect of TPA can not be expressed. Contrarily, in the experimental protocol of "colcemid first and TPAsecond", colcemid does not down-regulate PKCat all, and so whenTPAtreatment is applied anytime after colcemid addition, PKCis activated and functions on pathways driven by colcemid to express an inhibition of DNAsynthesis. The result that the inhibitory effect of DNAsynthesis was more extensive when the interval between addition of colcemid and TPAwas extended, suggests that the the inhibitory action of PKCis expressed in the progression of cells from late Gi to the S phase as reported in smooth muscle cells (8, 9).
a. b, c. d, e.
-28s -18s Fig. 4 . Induction of c-myc after 2 h-treatment with TPAin cells incubated with colcemid for 6 h. Go-arrested TIG-1 was treated with colcemid (10-6M) for 6 h and treated with TPA (10 ng/ml) for 30 min. Amount of c-myc mRNA was assayed by Northern blot analysis, a; unstimulated control, b; colcemid-treated for 2 h, c; TPA-treated for 2 h, d; colcemid-treated for 6 h and then TPA-treated for 2 h, and e; colcemid-treated for 6 h.
Activation and down regulation of PKCby TPA. To see whether the recovery from inhibition of DNA synthesis observed in "TPA first and colcemid second experiments" is due to the down regulation of PKC, the time course of downregulation of PKCwas monitored after TPA addition. PKCActivity in postnuclear fraction was regulated down to about 50%and 20%of control level at 3 h and 6h after TPAaddition, respectively. After 9 h, PKC activity was less than 10% of control level. This time course of PKCdownregulation was in good agreement with that of recovery from inhibition of DNAsynthesis shown in Fig. 2 (closed circles) . Next, to see whether PKCwas activated by TPAin "colcemid first and TPA second experiments", TPA was added at 6 h after colcemid addition and PKCactivation was monitored by two different methods. First, translocation of PKCto membranewas observed at 15 min after TPA addition (Fig. 3) . Second, c-myc mRNA accumulated 2 h after TPA addition in both G0-arrested and colcemid-treated cells (Fig. 4) . Accumulation of cfos mRNA also occurred 30 min after TPAaddition in both Go-arrested and colcemid-treated cells (data not shown). Treatment with colcemid alone did not bring about the accumulation of these mRNAs. These results indicated that TPAcould activate PKCeven at 6 h after colcemid addition. Effect ofstaurosporine on the induction ofDNAsynthesis. If an inhibitory effect, as well as stimulatory effect, on DNAsynthesis by TPA was mediated by PKC, it could be abolished when PKC was inhibited by metabolic inhibitors. To test this hypothesis, similar experiments as shown in Fig. 2 were carried out in the presence or absence of staurosporine. Fig. 5a shows the "TPAfirst and colcemid second" experiment. Since an induction of DNA synthesis by TPA alone was inhibited in the presence of staurosporine but that by colcemid was not, the remaining DNAsynthesis observed in the presence of staurosporine being attributable to the effect of colcemid alone. The induction of DNAsynthesis was reduced in the presence of staurosporine (Fig. 5a ). However, the inhibitory effect on DNAsynthesis by TPA was observed when TPAwas added soon after colcemid addition, and was not abolished even in the presence of staurosporine (Fig. 5a ). Fig. 5b showed that DNAsynthesis was reduced in the presence of staurosporine as compared with that in the absence of the in- hibitor. The inhibitory effect on DNAsynthesis by TPA was not abolished but appeared rather to be enhanced (Fig. 5b ). These observations suggest that PKCwhich mediates a stimulatory signal by.TPA for DNAsynthesis is inhibited by staurosporine but that PKC which mediates an inhibitory signal by TPA for DNAsynthesis is resistant to staurosporine. Induction of DNAsynthesis in PKCdeprived cells.
Since the presence of staurosporine-resistant PKChas not been reported in the course of the signal transduction process, other means should be used to confirm whether PKCis concerned with the inhibitory process.
Wethen carried out similar experiments as shown in Fig. 2 using PKC deprived cells. Subconfluent culture of TIG-1 was incubated in serum-deprived (0.5%) medium containing 100 ng/ml of TPA for 2 days. It was confirmed that 24-h incubation with TPAwas enough to down regulate PKCto a negligible level of activity. As expected, these cells were stimulated to synthesize DNAfollowing addition of serum, EGF, or colcemid, but not by TPA (Table III) . When these G0-arrested and PKC-deprived cells were stimulated with both TPA and colchicine, the extent of DNAinduction was largely constant, regardless of the order of addition of the two stimulants (Fig. 6 ). In these experiments, induction of '0 8 10 12
Time of 2nd growth factor addition (h) Kariya et al. (8) and Kawahara et al. (9) reported that an induction of DNAsynthesis by serum was reduced by TPAin rabbit aortic smooth muscle cells. Although both of their and our studies were on the inhibitory effect of TPAon an the induction of DNAsynthesis following stimulation with various mitogens, these two systems showed several differences: 1) In smooth muscle cells TPA alone did not stimulate DNA synthesis, whereas in TIG-1 cells TPA alone did stimulate DNA synthesis; 2) in smooth muscle cells TPAextensively reduced DNA synthesis after stimulation of cells with serum, whereas in TIG-1 cells it was only slightly reduced after stimulation with serum but was extensively reduced with colcemid; and 3) in smooth muscle cells there exists two forms of PKCs, those which are down regulation-sensitive and those which are -insensitive, and the former is concerned with both growth stimulation and growth repression, whereas in TIG-1 cells it is suggested that there exists staurosporine-sensitive and -insensitive PKCsand both of these are subject to down regulation. In both systems, the inhibitory effect of TPAon induction of DNAsynthesis was mediated by PKC, and PKCappeared to exert its inhibitory action at the Gi phase to block the progression of cells from the late Gi to the S phase.
Recently, four different but highly homologous PKCs, i.e. PKC-a, PKC-,81, PKC-/32, and PKC-r, have been identified as cDNAs (14, 21) and as purified enzymes (3, ll, 22) . Additionally, three other types of nPKCs, although less homologous to the conventional PKCs, were also reported (19). However, the functional discrimination of these PKCmolecules in the transduction processes of growth signal has yet to be clarified. Our results suggest, as one of several possible interpretations, that there are two forms of PKC; one of which is staurosporine-sensitive and acts as a mediatorof growth induction, and an other which is staurosporineinsensitive and acts as a mediator of growth repression, and may shed new light to differentiate each function of the PKC molecule family. However, in vitro assay of PKCactivity using a synthetic peptide as a substrate revealed the absence of staurosporine-resistant PKC (data not shown). A simple interpretation of this finding, although only one of possible interpretations, would be that some form of PKCis staurosporine-resistant toward physiological substrate(s) critical for growth repression. Studies on the possible presence of phosphorylation substrate(s) in vivo which are down regulationsensitive and staurosporine-resistant is under investigation. Since TPAactivated both forms of PKCand other mitogens such as serum, EGF, and colcemid appeared to bypass PKCactivation, it is of interest to distinguish the growth stimulatory or inhibitory factors that separately activate different forms of PKCleading to growth induction or growth repression. Studies on the action mechanisms of TGF-/3 which express an inhibitory effect on the induction of DNAsynthesis by serum in TIG-1 are currently in progress.
